Viewing Study NCT05938361


Ignite Creation Date: 2025-12-24 @ 12:37 PM
Ignite Modification Date: 2025-12-27 @ 9:20 PM
Study NCT ID: NCT05938361
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-09-24
First Post: 2023-05-30
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Efficacy of Tildrakizumab in Difficult-to-treat Areas in Psoriasis
Sponsor: Clin4all
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module